Fecal microbiota transplantation for the treatment of recurrent and severeClostridium difficileinfection in solid organ transplant recipients: A multicenter experience-Reference-Cited by-同舟云学术

Fecal microbiota transplantation for the treatment of recurrent and severeClostridium difficileinfection in solid organ transplant recipients: A multicenter experience

Published:2018-08-31 Issue:2 Volume:19 Page:501-511
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Cheng Yao-Wen¹^ORCID,Phelps Emmalee²,Ganapini Vincent¹,Khan Noor²,Ouyang Fangqian³,Xu Huiping³,Khanna Sahil⁴,Tariq Raseen⁴,Friedman-Moraco Rachel J.⁵,Woodworth Michael H.⁵^ORCID,Dhere Tanvi⁶,Kraft Colleen S.⁵⁷,Kao Dina⁸,Smith Justin⁸,Le Lien⁹,El-Nachef Najwa⁹,Kaur Nirmal¹⁰,Kowsika Sree¹⁰,Ehrlich Adam¹¹,Smith Michael¹¹,Safdar Nasia¹²¹³,Misch Elizabeth Ann¹²,Allegretti Jessica R.¹⁴,Flynn Ann¹⁵,Kassam Zain¹⁶,Sharfuddin Asif¹⁷,Vuppalanchi Raj²,Fischer Monika²

Affiliation:

1. Department of Medicine; Indiana University School of Medicine; Indianapolis IN USA

2. Division of Gastroenterology, Department of Medicine; Indiana University School of Medicine; Indianapolis IN USA

3. Department of Biostatistics; The Richard M. Fairbanks School of Public Health and School of Medicine, Indiana University; Indianapolis IN USA

4. Department of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA

5. Division of Infectious Diseases, Department of Medicine; Emory University; Atlanta GA USA

6. Division of Digestive Diseases, Department of Medicine; Emory University; Atlanta GA USA

7. Department of Pathology; Emory University; Atlanta GA USA

8. Division of Gastroenterology, Department of Medicine; University of Alberta; Edmonton Alberta Canada

9. Division of Gastroenterology, Department of Medicine; University of California San Francisco; San Francisco CA USA

10. Division of Gastroenterology, Department of Medicine; Henry Ford Medical Center; Detroit MI USA

11. Division of Gastroenterology, Department of Medicine; Temple University; Philadelphia PA USA

12. Division of Infectious Diseases, Department of Medicine; University of Wisconsin; School of Medicine and Public Health; Madison WI USA

13. William S. Middleton Memorial Veterans Hospital; Madison WI USA

14. Division of Gastroenterology, Hepatology, and Endoscopy, Department of Medicine; Brigham and Women’s Hospital; Boston MA USA

15. Division of Gastroenterology, Department of Medicine; University of Utah; Salt Lake City, UT USA

16. OpenBiome; Somerville MA USA

17. Division of Nephrology, Department of Medicine; Indiana University School of Medicine; Indianapolis IN USA

Funder

National Center for Advancing Translational Sciences

IU GI Divisional Research Grant

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.15058/fullpdf

Reference69 articles.

1. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort study;Ma;Ann Intern Med,2017

2. Burden of Clostridium difficile infection in the United States;Lessa;N Engl J Med,2015

3. The burden of Clostridium difficile in surgical patients in the United States;Zerey;Surg Infect,2007

4. Multicenter study of Clostridium difficile infection rates from 2000 to 2006;Dubberke;Infect Control Hosp Epidemiol,2010

5. Clostridium difficile colitis in solid organ transplantation-a single-center experience;Stelzmueller;Dig Dis Sci,2007

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney transplantation and gut microbiota;Clinical Kidney Journal;2024-08-01

2. Recurrent Clostridioides difficile Infection and Outcome of Fecal Microbiota Transplantation Use: A Population-Based Assessment;Open Forum Infectious Diseases;2024-06-15

3. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options;Clinical Microbiology Reviews;2024-06-13

4. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines;Journal of Hospital Infection;2024-06

5. Clostridioides difficile infection in inflammatory bowel disease: a clinical review;Expert Review of Anti-infective Therapy;2024-05-02